Will Theravance Biopharma (TBPH) beat quarterly earnings?

As of market creation, Theravance Biopharma is estimated to release earnings on February 25, 2026. The Street consensus estimate for Theravance Biopharma's GAAP EPS for the relevant quarter is $1.01 as of market creation. This market will resolve to "Yes" if Theravance Biopharma reports GAAP EPS greater than $1.01 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earning